Histology and Cytology Market Size Worth $37.08 Billion By 2028 | CAGR: 13.3%

Histology and Cytology Market Size Worth $37.08 Billion By 2028 | CAGR: 13.3%

The global histology and cytology market size is expected to reach USD 37.08 billion by 2028 according to a new study by Polaris Market Research. The report “Histology and Cytology Market Share, Size, Trends, Industry Analysis Report, By Examination Type (Histology, Cytology); By Product (Instrument & Analysis Software System, Consumables & Reagents); By End-Use (Life Sciences, Clinical Diagnostics); By Regions; Segment Forecast, 2021 - 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.


Histology is a branch of biology that deals with the microscopic analysis of tissues for the diagnosis of chronic disorders mainly in cancer and also in other conditions such as autoimmune disorders and infections. Histology involves tissue preparation, tissue staining, hybridization, and microscopy. Whereas, cytology is a branch of biology that deals with the microscopic analysis of cells for the diagnosis of various chronic disorders.


Virtual microscopy is one of the most significant market developments in microscopy and immunohistochemistry, and it is estimated to drive market demand for histology and cytology tests. Users can create virtual slides, which can then be stored on a network server and accessed by other users via virtual microscopy.


Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/histology-cytology-market/request-for-sample


The increasing incidence of cancer globally is the main driving force for the market growth of the histology and cytology. Every year, more than 19 million cancer cases are diagnosed worldwide, and the most common type of cancer is breast cancer, which is diagnosed in more than 2 million people every year. Cancer is an emerging healthcare problem in Africa and South Africa could see an estimated increase of 78% cancer cases, by 2030.


The emergence of digital platforms powered by AI along with new product launches and acquisitions is expected to drive the global market for histology and cytology during the forecast period. ONCORE Pro, an automated staining system was launched by Biocare Medical, LLC in January 2021 that has applications in Immunohistochemistry (IHC). ONCORE Pro System can process 36 slides simultaneously that will help in-vitro diagnostic labs to improvise their throughput of sample processing.


Mosaic Laboratories that offer histology services was acquired by Caprion-HistoGeneX in January 2021. The acquisition will help Caprion-HistoGeneX to improve its services in histopathology biomarker analysis for clinical trials. Mosaic is specialized in multiplex IHC with spectral imaging, and it has well-proven capabilities to support exploratory biomarker analysis services for clinical and preclinical trials.


Market Participants such as Roche Ltd., Thermo Fisher Scientific, Inc., Hologic, Inc., Becton, Dickinson & Company, Merck KGaA, Danaher Corporation, Abbott, Sysmex Corporation, Koninklijke Philips N.V., and Trivitron Healthcare are some of the key players operating in the global market.


Polaris Market Research has segmented the histology and cytology market report on the basis of type of examination, product, end-users, and region:


Histology and Cytology, Examination Type (Revenue - USD Million, 2016 - 2028)

  • Histology
    • By Technique
      • Microscopy
      • Immunohistochemistry
      • Molecular pathology
      • Cryostat & Microtomy
  • Cytology
    • By Technique
      • Microscopy
      • Immunohistochemistry
      • Molecular pathology
      • Cryostat & Microtomy
    • By Application
      • Cervical Cancer
      • Breast Cancer
      • Bladder CancerLung Cancer
      • Other Cancers

Histology and Cytology, Product Outlook (Revenue - USD Million, 2016 - 2028)

  • Instruments and Analysis Software System
  • Consumable and Reagents

Histology and Cytology, End-Use Outlook (Revenue - USD Million, 2016 - 2028)

  • Life Sciences
  • Clinical Diagnostics

Histology and Cytology, Regional Outlook (Revenue - USD Million, 2016 - 2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Netherlands
    • Austria
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Malaysia
    • Indonesia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • South Africa